| SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes HCALBN W Sungnak, N Huang, C Bécavin, M Berg, R Queen, M Litvinukova, C ... Nature Medicine 26 (5), 681–687, 2020 | 2350 | 2020 |
| SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424, 2021 | 2132 | 2021 |
| The “silent” global burden of congenital cytomegalovirus S Manicklal, VC Emery, T Lazzarotto, SB Boppana, RK Gupta Clinical microbiology reviews 26 (1), 86-102, 2013 | 992 | 2013 |
| SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 859 | 2021 |
| Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England FNM COVID-19 Genomics UK (COG-UK) consortium, Flaxman S, Ratmann O, Bhatt S ... Nature, 2021 | 859 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 704 | 2021 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 598 | 2021 |
| The biological and clinical significance of emerging SARS-CoV-2 variants K Tao, PL Tzou, J Nouhin, RK Gupta, T de Oliveira, SL Kosakovsky Pond, ... Nature Reviews Genetics 22 (12), 757-773, 2021 | 595 | 2021 |
| Screening of Healthcare Workers for SARS-CoV-2 Highlights the Role of Asymptomatic Carriage in COVID-19 Transmission ML Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK, Forrest S, Young J ... ELIFE 11 (9), e58728, 2020 | 554* | 2020 |
| HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ... Nature 568 (7751), 244-248, 2019 | 540 | 2019 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 479 | 2021 |
| Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global … RK Gupta, MR Jordan, BJ Sultan, A Hill, DHJ Davis, J Gregson, ... The Lancet 380 (9849), 1250-1258, 2012 | 437 | 2012 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 424 | 2022 |
| Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 DA Collier, IATM Ferreira, P Kotagiri, RP Datir, EY Lim, E Touizer, B Meng, ... Nature 596 (7872), 417-422, 2021 | 422 | 2021 |
| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression … RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ... The Lancet infectious diseases 18 (3), 346-355, 2018 | 355 | 2018 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 109292, 2021 | 308 | 2021 |
| Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and … RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ... The Lancet infectious diseases 9 (7), 409-417, 2009 | 306 | 2009 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study CJ Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, Kläser K ... Lancet Public Health, 2021 | 291 | 2021 |
| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study TS Group The Lancet Infectious Diseases, 2016 | 252 | 2016 |
| Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials R Gupta, A Hill, AW Sawyer, D Pillay Clinical infectious diseases 47 (5), 712-722, 2008 | 241 | 2008 |
Greg Towersuniversity college londonVerifisert e-postadresse på ucl.ac.uk
